IC‐P‐015: Evaluation of the pons as a reference region for amyloid PET in Alzheimer's disease clinical trials

MLA

Robert H. Brashear, et al. “IC‐P‐015: Evaluation of the Pons as a Reference Region for Amyloid PET in Alzheimer’s Disease Clinical Trials.” Alzheimer’s & Dementia, vol. 9, July 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........aa0d80f13a4431a694fc6995c3496da4&authtype=sso&custid=ns315887.

APA

Robert H. Brashear, Andrea S. Les, Michael Grundman, Mark E. Schmidt, Scot Styren, Eric C. Yuen, Robert A. Koeppe, Derek L. G. Hill, Enchi Liu, Bradley T. Wyman, Richard Margolin, & Gregg Keith M. (2013). IC‐P‐015: Evaluation of the pons as a reference region for amyloid PET in Alzheimer’s disease clinical trials. Alzheimer’s & Dementia, 9.

Chicago

Robert H. Brashear, Andrea S. Les, Michael Grundman, Mark E. Schmidt, Scot Styren, Eric C. Yuen, Robert A. Koeppe, et al. 2013. “IC‐P‐015: Evaluation of the Pons as a Reference Region for Amyloid PET in Alzheimer’s Disease Clinical Trials.” Alzheimer’s & Dementia 9 (July). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........aa0d80f13a4431a694fc6995c3496da4&authtype=sso&custid=ns315887.